By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427



Company News
FDA Turns Down Both BioMarin (BMRN) and Sarepta (SRPT)’s DMD Drug Applications, Stocks Plunge 1/15/2016 6:00:13 AM
FDA Rejects BioMarin (BMRN)'s Much-Anticipated DMD Drug 1/14/2016 7:32:37 AM
BioMarin (BMRN) CEO Expects 2016 to be a Billion Dollar Year for the Company, Opens New Research Center to House 700 Employees 1/12/2016 6:33:10 AM
BioMarin (BMRN), Raptor (RPTP), Buck Institute for Age Research Lead Marin Biotech Boom 12/31/2015 1:37:17 PM
Former Sarepta (SRPT) CEO's Feelings About BioMarin (BMRN)'s Drug Panel 11/30/2015 6:52:56 AM
BioMarin (BMRN) Stock Halted as FDA Bashes Muscle Wasting Drug 11/25/2015 5:58:28 AM
Investors Hold Their Breath as BioMarin (BMRN)'s DMD Drug Gets Grilled by the FDA Today 11/24/2015 6:15:08 AM
NICE Recommends BioMarin (BMRN)’s Vimizim (Elosulfase Alfa) For The Treatment Of Morquio A Syndrome In England 11/23/2015 11:15:06 AM
BioMarin (BMRN) Release: FDA Posts Briefing Documents For Advisory Committee Meeting To Review Kyndrisa (Drisapersen) For The Potential Treatment Of Duchenne Muscular Dystrophy Amendable To Exon 51 Skipping 11/20/2015 10:47:02 AM
BioMarin (BMRN) Stocks Drop After FDA Panel is Critical of DMD Treatment Drisapersen 11/20/2015 8:19:15 AM